IMP4
gene geneOn this page
Also known as MGC19606BXDC4
Summary
IMP4 (IMP U3 small nucleolar ribonucleoprotein 4, HGNC:30856) is a protein-coding gene on chromosome 2q21.1, encoding U3 small nucleolar ribonucleoprotein protein IMP4 (Q96G21). Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). It is a common-essential gene (DepMap: required in 99.4% of cancer cell lines).
The protein encoded by this gene, along with IMP3 and MPP10, is part of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP) complex. This complex is necessary for the early cleavage steps of pre-18S ribosomal RNA processing. Several transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 92856 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 72 total
- Cancer dependency (DepMap): dependent in 99.4% of screened cell lines (common-essential)
- MANE Select transcript:
NM_033416
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30856 |
| Approved symbol | IMP4 |
| Name | IMP U3 small nucleolar ribonucleoprotein 4 |
| Location | 2q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC19606, BXDC4 |
| Ensembl gene | ENSG00000136718 |
| Ensembl biotype | protein_coding |
| OMIM | 612981 |
| Entrez | 92856 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 12 protein_coding, 11 retained_intron, 1 nonsense_mediated_decay
ENST00000259239, ENST00000409649, ENST00000409935, ENST00000428740, ENST00000452955, ENST00000456713, ENST00000460100, ENST00000460766, ENST00000462357, ENST00000462392, ENST00000464432, ENST00000470672, ENST00000473689, ENST00000475074, ENST00000477375, ENST00000490895, ENST00000495606, ENST00000859438, ENST00000859439, ENST00000859440, ENST00000859441, ENST00000927812, ENST00000951188, ENST00000951189
RefSeq mRNA: 16 — MANE Select: NM_033416
NM_001320304, NM_001320305, NM_001320306, NM_001320307, NM_001320309, NM_001320310, NM_001320311, NM_001371725, NM_001371726, NM_001371728, NM_001371730, NM_001371731, NM_001371732, NM_001371733, NM_001371734, NM_033416
CCDS: CCDS2160
Canonical transcript exons
ENST00000259239 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070705 | 130346356 | 130347967 |
| ENSE00001813756 | 130342897 | 130342935 |
| ENSE00003520818 | 130343086 | 130343194 |
| ENSE00003529709 | 130345567 | 130345699 |
| ENSE00003553218 | 130346201 | 130346274 |
| ENSE00003635872 | 130346018 | 130346112 |
| ENSE00003640369 | 130345779 | 130345933 |
| ENSE00003657765 | 130344629 | 130344712 |
| ENSE00003692975 | 130345376 | 130345485 |
Expression profiles
Bgee: expression breadth ubiquitous, 286 present calls, max score 97.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 50.5899 / max 274.1558, expressed in 1825 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 22501 | 50.5899 | 1825 |
Top tissues by expression
298 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 97.28 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.42 | gold quality |
| muscle of leg | UBERON:0001383 | 95.97 | gold quality |
| body of stomach | UBERON:0001161 | 95.70 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.49 | gold quality |
| lower esophagus | UBERON:0013473 | 95.48 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.39 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.36 | gold quality |
| left coronary artery | UBERON:0001626 | 95.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 95.19 | gold quality |
| granulocyte | CL:0000094 | 95.18 | gold quality |
| apex of heart | UBERON:0002098 | 95.16 | gold quality |
| triceps brachii | UBERON:0001509 | 95.15 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.13 | gold quality |
| coronary artery | UBERON:0001621 | 94.99 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.95 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 94.95 | gold quality |
| right coronary artery | UBERON:0001625 | 94.91 | gold quality |
| muscle organ | UBERON:0001630 | 94.91 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 94.91 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.86 | gold quality |
| popliteal artery | UBERON:0002250 | 94.70 | gold quality |
| tibial artery | UBERON:0007610 | 94.69 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.66 | gold quality |
| omental fat pad | UBERON:0010414 | 94.66 | gold quality |
| peritoneum | UBERON:0002358 | 94.64 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.64 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.55 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6379 | no | 721.53 |
| E-MTAB-7249 | no | 223.68 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
51 targeting IMP4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-2053 | 99.57 | 69.15 | 1635 |
| HSA-MIR-141-5P | 99.57 | 67.86 | 897 |
| HSA-MIR-143-3P | 99.49 | 69.05 | 1457 |
| HSA-MIR-4770 | 99.49 | 69.09 | 1451 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-6088 | 99.29 | 68.45 | 1284 |
| HSA-MIR-196A-3P | 99.19 | 67.34 | 1204 |
| HSA-MIR-505-3P | 99.19 | 69.71 | 896 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.4% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 1)
- DDX10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4. (PMID:33973712)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | imp4 | ENSDARG00000054540 |
| mus_musculus | Imp4 | ENSMUSG00000026127 |
| rattus_norvegicus | Imp4 | ENSRNOG00000013285 |
| drosophila_melanogaster | CG11920 | FBGN0039274 |
| caenorhabditis_elegans | WBGENE00014083 |
Paralogs (1): RPF1 (ENSG00000117133)
Protein
Protein identifiers
U3 small nucleolar ribonucleoprotein protein IMP4 — Q96G21 (reviewed: Q96G21)
Alternative names: Brix domain-containing protein 4
All UniProt accessions (6): B8ZZ47, B9A008, Q96G21, E7ENR5, F8WCN0, H0Y714
UniProt curated annotations — full annotation on UniProt →
Function. Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome.
Subunit / interactions. Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3. Component of a heterotrimeric complex containing IMP3, IMP4 and MPHOSPH10. Interacts with MPHOSPH10.
Subcellular location. Nucleus. Nucleolus.
RefSeq proteins (16): NP_001307233, NP_001307234, NP_001307235, NP_001307236, NP_001307238, NP_001307239, NP_001307240, NP_001358654, NP_001358655, NP_001358657, NP_001358659, NP_001358660, NP_001358661, NP_001358662, NP_001358663, NP_219484* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007109 | Brix | Domain |
| IPR044281 | IMP4/RPF1 | Family |
Pfam: PF04427
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7MQA | ELECTRON MICROSCOPY | 2.7 |
| 7MQ8 | ELECTRON MICROSCOPY | 3.6 |
| 7MQ9 | ELECTRON MICROSCOPY | 3.87 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96G21-F1 | 89.47 | 0.57 |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-6790901 | rRNA modification in the nucleus and cytosol |
| R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol |
| R-HSA-72312 | rRNA processing |
| R-HSA-8868773 | rRNA processing in the nucleus and cytosol |
| R-HSA-8953854 | Metabolism of RNA |
MSigDB gene sets: 151 (showing top):
GSE45365_NK_CELL_VS_BCELL_DN, GOBP_RIBOSOME_BIOGENESIS, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_MATURATION_OF_SSU_RRNA, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, TAANNYSGCG_UNKNOWN, REACTOME_METABOLISM_OF_RNA, GOCC_90S_PRERIBOSOME, GOCC_PRERIBOSOME, GOCC_SMALL_SUBUNIT_PROCESSOME, GOCC_NUCLEOLUS, BLALOCK_ALZHEIMERS_DISEASE_DN
GO Biological Process (4): rRNA processing (GO:0006364), maturation of SSU-rRNA (GO:0030490), ribosomal small subunit biogenesis (GO:0042274), ribosome biogenesis (GO:0042254)
GO Molecular Function (4): snoRNA binding (GO:0030515), rRNA primary transcript binding (GO:0042134), protein binding (GO:0005515), rRNA binding (GO:0019843)
GO Cellular Component (8): fibrillar center (GO:0001650), nucleoplasm (GO:0005654), nucleolus (GO:0005730), preribosome (GO:0030684), small-subunit processome (GO:0032040), Mpp10 complex (GO:0034457), nucleus (GO:0005634), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| rRNA processing in the nucleus and cytosol | 2 |
| Metabolism of RNA | 1 |
| rRNA processing | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleolus | 3 |
| ribosome biogenesis | 2 |
| ribonucleoprotein complex biogenesis | 2 |
| RNA binding | 2 |
| cellular anatomical structure | 2 |
| nuclear lumen | 2 |
| nuclear protein-containing complex | 2 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| rRNA processing | 1 |
| ribosomal small subunit biogenesis | 1 |
| rRNA binding | 1 |
| binding | 1 |
| intracellular membraneless organelle | 1 |
| ribonucleoprotein complex | 1 |
| preribosome | 1 |
| t-UTP complex | 1 |
| 90S preribosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1998 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IMP4 | MRPL2 | Q5T653 | 576 |
| IMP4 | MRPS12 | O15235 | 544 |
| IMP4 | MRPL17 | Q9NRX2 | 480 |
| IMP4 | DDX28 | Q9NUL7 | 447 |
| IMP4 | MRPL11 | Q9Y3B7 | 446 |
| IMP4 | CSDC2 | Q9Y534 | 400 |
| IMP4 | ORC1 | Q13415 | 393 |
| IMP4 | MXRA8 | Q9BRK3 | 365 |
| IMP4 | ACAT2 | Q9BWD1 | 357 |
| IMP4 | RPF2 | Q9H7B2 | 353 |
| IMP4 | GNL2 | Q13823 | 352 |
| IMP4 | IMP3 | Q9NV31 | 352 |
| IMP4 | ZFPL1 | O95159 | 351 |
| IMP4 | BRIX1 | Q8TDN6 | 351 |
| IMP4 | NIP7 | Q9Y221 | 350 |
IntAct
121 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| ZBTB7B | IMP4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| IMP4 | ZBTB7B | psi-mi:“MI:0915”(physical association) | 0.670 |
| IMP3 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.670 |
| NOP53 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| ZBTB7B | IMP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IMP4 | MPHOSPH10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM34 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| ILF2 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL37A | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL30 | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18A | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| KRR1 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| IMP4 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| IMP4 | LTB4R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RRP1B | ZNF785 | psi-mi:“MI:0914”(association) | 0.350 |
| Prdm16 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (139): IMP4 (Two-hybrid), IMP4 (Affinity Capture-MS), IMP4 (Co-fractionation), IMP4 (Co-fractionation), IMP4 (Co-fractionation), NAT10 (Co-fractionation), NOL10 (Co-fractionation), IMP4 (Reconstituted Complex), IMP4 (Affinity Capture-MS), IMP4 (Two-hybrid), IMP4 (Two-hybrid), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS)
ESM2 similar proteins: G0S488, G0S616, G0SF80, O13823, O14180, O14206, O62518, P12531, P30190, P34524, P36160, P38789, P38805, P53941, P54073, Q01879, Q08235, Q09817, Q0VD01, Q12153, Q196X4, Q54DJ0, Q54JN0, Q54N44, Q5PQR5, Q5R631, Q5R947, Q5RJS9, Q6BYD9, Q6C804, Q6FNN7, Q6IQU6, Q755T8, Q7S302, Q7TND5, Q8AVP1, Q8VHZ7, Q96G21, Q96X45, Q9ASU7
Diamond homologs: O13823, O14180, O62518, P53941, P54073, Q0VD01, Q5PQR5, Q5R631, Q5R947, Q5RJS9, Q6BYD9, Q6C804, Q6FNN7, Q6IQU6, Q755T8, Q7TND5, Q8AVP1, Q8VHZ7, Q96G21, Q9H9Y2, Q9VKB4, Q9YC08, P38805, Q975H1, Q5JDM5, O26776, O74104, Q467K0, Q58012, Q6M0M3, Q8TQ11, Q8TZI2, Q9UXB9, Q9V200
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MPHOSPH10 | “up-regulates activity” | IMP4 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 110 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Peptide chain elongation | 19 | 35.5× | 2e-23 |
| Viral mRNA Translation | 19 | 35.5× | 2e-23 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 19 | 35.1× | 2e-23 |
| Selenocysteine synthesis | 19 | 33.6× | 4e-23 |
| Eukaryotic Translation Termination | 19 | 33.6× | 4e-23 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 19 | 32.9× | 4e-23 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 19 | 32.9× | 4e-23 |
| Formation of a pool of free 40S subunits | 19 | 31.3× | 1e-22 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 21 | 39.7× | 8e-26 |
| ribosomal large subunit biogenesis | 7 | 31.7× | 2e-07 |
| rRNA processing | 17 | 24.6× | 3e-17 |
| ribosomal small subunit biogenesis | 10 | 23.2× | 2e-09 |
| translation | 20 | 21.0× | 7e-19 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 14.9× | 2e-04 |
| negative regulation of translation | 6 | 12.0× | 7e-04 |
| RNA processing | 5 | 11.2× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1866 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:130345793:A:C | S152R | 0.998 |
| 2:130345795:C:A | S152R | 0.998 |
| 2:130345795:C:G | S152R | 0.998 |
| 2:130345796:C:G | H153D | 0.998 |
| 2:130345818:C:A | A160D | 0.998 |
| 2:130346103:T:A | I227K | 0.998 |
| 2:130345459:A:C | S94R | 0.997 |
| 2:130345461:T:A | S94R | 0.997 |
| 2:130345461:T:G | S94R | 0.997 |
| 2:130345644:C:G | C128W | 0.997 |
| 2:130345809:G:A | G157D | 0.997 |
| 2:130345643:G:A | C128Y | 0.996 |
| 2:130345667:T:C | L136P | 0.996 |
| 2:130345791:T:A | V151D | 0.996 |
| 2:130346103:T:G | I227R | 0.996 |
| 2:130346112:G:C | R230P | 0.996 |
| 2:130345402:T:C | Y75H | 0.995 |
| 2:130345469:T:A | L97H | 0.995 |
| 2:130345642:T:C | C128R | 0.995 |
| 2:130345808:G:C | G157R | 0.995 |
| 2:130345890:C:A | P184H | 0.995 |
| 2:130345926:G:A | G196D | 0.995 |
| 2:130346253:G:A | G248R | 0.995 |
| 2:130346253:G:C | G248R | 0.995 |
| 2:130346254:G:A | G248E | 0.995 |
| 2:130346365:T:A | I258N | 0.995 |
| 2:130345478:T:C | F100S | 0.994 |
| 2:130345567:G:A | E103K | 0.994 |
| 2:130345571:T:C | L104P | 0.994 |
| 2:130345605:C:A | N115K | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000095126 (2:130341416 C>T), RS1000327396 (2:130344162 A>T), RS1000490505 (2:130342695 A>C,G), RS1001074332 (2:130347813 C>T), RS1001333652 (2:130347597 C>A), RS1001713789 (2:130345496 G>T), RS1001756408 (2:130345041 C>G), RS1002322825 (2:130341306 G>C), RS1003066533 (2:130342516 G>T), RS1003265265 (2:130343879 G>T), RS1003386114 (2:130344150 A>G), RS1003677034 (2:130341995 T>A,C), RS1003938501 (2:130344485 C>A,T), RS1004940446 (2:130345807 T>C), RS1005205304 (2:130343522 G>A)
Disease associations
OMIM: gene MIM:612981 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment | 5 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 2 |
| bisphenol A | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Coumestrol | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Plant Extracts | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Silicon Dioxide | increases expression | 1 |
| T-2 Toxin | increases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.